BGLUX
Price
$61.63
Change
+$0.81 (+1.33%)
Updated
Aug 21 closing price
Net Assets
1.31B
NPFCX
Price
$70.50
Change
+$0.67 (+0.96%)
Updated
Aug 21 closing price
Net Assets
165.87B
Interact to see
Advertisement

BGLUX vs NPFCX

BGLUX vs NPFCX Comparison Chart in %
View a ticker or compare two or three
VS
BGLUX vs. NPFCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLUX is a Buy and NPFCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 166B vs. BGLUX (1.31B). NPFCX pays higher dividends than BGLUX: NPFCX (0.33) vs BGLUX (0.17). BGLUX was incepted earlier than NPFCX: BGLUX (10 years) vs NPFCX (25 years). NPFCX (1.47) is less costly to investors than BGLUX (0.94). NPFCX is a more actively managed with annual turnover of: 23.00 vs. BGLUX (9.00). NPFCX has a lower initial minimum investment than BGLUX: NPFCX (250) vs BGLUX (5000000). BGLUX annual gain was more profitable for investors over the last year : 38.20 vs. NPFCX (7.64). BGLUX return over 5 years is better than : 13.34 vs. NPFCX (10.82).
BGLUXNPFCXBGLUX / NPFCX
Total Expense Ratio0.901.4761%
Annual Report Gross Expense Ratio0.941.4764%
Fund Existence10 years25 years-
Gain YTD21.3197.617280%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.31B166B1%
Annual Yield % from dividends0.170.3352%
Returns for 1 year38.207.64500%
Returns for 3 years121.8839.60308%
Returns for 5 years13.3410.82123%
Returns for 10 yearsN/A96.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFMCX20.160.23
+1.15%
Acuitas US Microcap Institutional
JFCCX33.650.25
+0.75%
JHancock Fundamental All Cap Core C
TLVIX38.450.27
+0.71%
Thrivent Large Cap Value S
MXERX7.010.04
+0.57%
Empower S&P SmallCap 600® Index Instl
FOCPX30.21N/A
N/A
Fidelity OTC